- Recommendation ID
- NG198/1
- Question
Oral isotretinoin treatment: What is the efficacy of reduced dose oral isotretinoin in the management of acne vulgaris?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale section on oral isotretinoin treatment.
Full details of the evidence and the committee's discussion are in evidence review F1: management options for moderate to severe acne – network meta-analyses.
Source guidance details
- Comes from guidance
- Acne vulgaris: management
- Number
- NG198
- Date issued
- June 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/06/2021 |